Successful commercialisation requires detailed strategic planning to successfully execute all the steps from biomarker discovery, clinical validation and reimbursement to successfully bring your product to market. Each of these development stages is critical and previous experience in this area is important to maximise the chance of success.

Permedx consultants have a proven track record in the development and implementation of strategic plans commercialisation for personalised medicine. Previous medicine personalised projects are currently being marketed in the US.

With our past record in commercialisation of diagnostic assays, Permedx and its partners can assist you in successfully bringing your product to market.